| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 66.777 | 154.407 | 162.717 | 308.554 | 277.144 | 219.644 | 230.726 | 202.667 | 240.309 | 255.614 |
| Total Income - EUR | 66.750 | 154.408 | 175.341 | 309.480 | 278.741 | 222.103 | 230.729 | 203.753 | 249.341 | 261.117 |
| Total Expenses - EUR | 57.744 | 79.171 | 163.490 | 200.641 | 203.357 | 164.669 | 197.330 | 186.981 | 221.393 | 253.831 |
| Gross Profit/Loss - EUR | 9.005 | 75.237 | 11.851 | 108.838 | 75.384 | 57.434 | 33.400 | 16.772 | 27.948 | 7.286 |
| Net Profit/Loss - EUR | 7.497 | 73.985 | 10.179 | 105.752 | 72.611 | 55.634 | 31.139 | 14.786 | 25.587 | 457 |
| Employees | 17 | 26 | 26 | 28 | 24 | 23 | 9 | 8 | 7 | 8 |
Check the financial reports for the company - Corisimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.313 | 20.034 | 176.567 | 156.133 | 135.677 | 118.815 | 99.681 | 82.590 | 68.351 | 54.113 |
| Current Assets | 10.227 | 19.326 | 194.574 | 125.446 | 107.919 | 116.383 | 25.690 | 19.519 | 31.286 | 33.769 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.515 |
| Receivables | 7.804 | 11.571 | 186.478 | 10.496 | 7.196 | 7.560 | 6.292 | 12.335 | 20.359 | 20.551 |
| Cash | 2.424 | 7.755 | 8.097 | 114.950 | 100.722 | 108.823 | 19.398 | 7.184 | 10.927 | 7.704 |
| Shareholders Funds | -88.445 | -13.557 | -3.149 | 102.660 | 173.325 | 225.675 | 116.351 | 87.910 | 83.373 | 71.204 |
| Social Capital | 45 | 45 | 44 | 43 | 84 | 85 | 83 | 83 | 83 | 82 |
| Debts | 120.985 | 52.918 | 209.217 | 18.640 | 16.850 | 9.523 | 10.025 | 14.246 | 16.273 | 16.745 |
| Income in Advance | 0 | 0 | 165.073 | 160.278 | 53.421 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Corisimed S.r.l.